PMC:7354481 / 10587-10745 JSONTXT

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T98","span":{"begin":1,"end":3},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"},{"id":"T99","span":{"begin":9,"end":12},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T100","span":{"begin":152,"end":154},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"}],"text":"[18]. It has also been reported that anti-miR-based HCV therapy is genotype independent, which makes it safe, effective and well tolerated by patients [22].\nI"}

{"project":"LitCovid-sentences","denotations":[{"id":"T67","span":{"begin":6,"end":156},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"[18]. It has also been reported that anti-miR-based HCV therapy is genotype independent, which makes it safe, effective and well tolerated by patients [22].\nI"}

{"project":"2_test","denotations":[{"id":"32512929-22751007-144200710","span":{"begin":1,"end":3},"obj":"22751007"},{"id":"32512929-17943132-144200711","span":{"begin":152,"end":154},"obj":"17943132"}],"text":"[18]. It has also been reported that anti-miR-based HCV therapy is genotype independent, which makes it safe, effective and well tolerated by patients [22].\nI"}

{"project":"LitCovid-PubTator","denotations":[{"id":"165","span":{"begin":142,"end":150},"obj":"Species"},{"id":"169","span":{"begin":52,"end":55},"obj":"Species"}],"attributes":[{"id":"A165","pred":"tao:has_database_id","subj":"165","obj":"Tax:9606"},{"id":"A169","pred":"tao:has_database_id","subj":"169","obj":"Tax:11103"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"[18]. It has also been reported that anti-miR-based HCV therapy is genotype independent, which makes it safe, effective and well tolerated by patients [22].\nI"}